These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20332212)

  • 1. Osteoclast-derived matrix metalloproteinase-9 directly affects angiogenesis in the prostate tumor-bone microenvironment.
    Bruni-Cardoso A; Johnson LC; Vessella RL; Peterson TE; Lynch CC
    Mol Cancer Res; 2010 Apr; 8(4):459-70. PubMed ID: 20332212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis.
    Thiolloy S; Halpern J; Holt GE; Schwartz HS; Mundy GR; Matrisian LM; Lynch CC
    Cancer Res; 2009 Aug; 69(16):6747-55. PubMed ID: 19679556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.
    Kaliski A; Maggiorella L; Cengel KA; Mathe D; Rouffiac V; Opolon P; Lassau N; Bourhis J; Deutsch E
    Mol Cancer Ther; 2005 Nov; 4(11):1717-28. PubMed ID: 16275993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer-derived MMP-3 controls intrinsic cell growth and extrinsic angiogenesis.
    Frieling JS; Li T; Tauro M; Lynch CC
    Neoplasia; 2020 Oct; 22(10):511-521. PubMed ID: 32896761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoclasts are important for bone angiogenesis.
    Cackowski FC; Anderson JL; Patrene KD; Choksi RJ; Shapiro SD; Windle JJ; Blair HC; Roodman GD
    Blood; 2010 Jan; 115(1):140-9. PubMed ID: 19887675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment.
    Deryugina EI; Zajac E; Juncker-Jensen A; Kupriyanova TA; Welter L; Quigley JP
    Neoplasia; 2014 Oct; 16(10):771-88. PubMed ID: 25379015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases.
    Pivetta E; Scapolan M; Pecolo M; Wassermann B; Abu-Rumeileh I; Balestreri L; Borsatti E; Tripodo C; Colombatti A; Spessotto P
    Breast Cancer Res; 2011 Oct; 13(5):R105. PubMed ID: 22032644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
    Littlepage LE; Sternlicht MD; Rougier N; Phillips J; Gallo E; Yu Y; Williams K; Brenot A; Gordon JI; Werb Z
    Cancer Res; 2010 Mar; 70(6):2224-34. PubMed ID: 20215503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
    Nemeth JA; Yousif R; Herzog M; Che M; Upadhyay J; Shekarriz B; Bhagat S; Mullins C; Fridman R; Cher ML
    J Natl Cancer Inst; 2002 Jan; 94(1):17-25. PubMed ID: 11773278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
    Kong D; Li Y; Wang Z; Banerjee S; Sarkar FH
    Cancer Res; 2007 Apr; 67(7):3310-9. PubMed ID: 17409440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment.
    Thiolloy S; Edwards JR; Fingleton B; Rifkin DB; Matrisian LM; Lynch CC
    PLoS One; 2012; 7(1):e29862. PubMed ID: 22238668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.
    Mohamedali KA; Li ZG; Starbuck MW; Wan X; Yang J; Kim S; Zhang W; Rosenblum MG; Navone NM
    Clin Cancer Res; 2011 Apr; 17(8):2328-38. PubMed ID: 21343372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch3 promotes prostate cancer-induced bone lesion development via MMP-3.
    Ganguly SS; Hostetter G; Tang L; Frank SB; Saboda K; Mehra R; Wang L; Li X; Keller ET; Miranti CK
    Oncogene; 2020 Jan; 39(1):204-218. PubMed ID: 31467432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells.
    Andersen TL; del Carmen Ovejero M; Kirkegaard T; Lenhard T; Foged NT; Delaissé JM
    Bone; 2004 Nov; 35(5):1107-19. PubMed ID: 15542036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation.
    Ortega N; Wang K; Ferrara N; Werb Z; Vu TH
    Dis Model Mech; 2010; 3(3-4):224-35. PubMed ID: 20142327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between focal adhesion kinase and matrix metalloproteinase-9 expression in prostate adenocarcinoma and their influence on the progression of prostatic adenocarcinoma.
    Ok Atılgan A; Özdemir BH; Yılmaz Akçay E; Tepeoğlu M; Börcek P; Dirim A
    Ann Diagn Pathol; 2020 Apr; 45():151480. PubMed ID: 32106037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.
    Dong Z; Bonfil RD; Chinni S; Deng X; Trindade Filho JC; Bernardo M; Vaishampayan U; Che M; Sloane BF; Sheng S; Fridman R; Cher ML
    Am J Pathol; 2005 Apr; 166(4):1173-86. PubMed ID: 15793297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones.
    Engsig MT; Chen QJ; Vu TH; Pedersen AC; Therkidsen B; Lund LR; Henriksen K; Lenhard T; Foged NT; Werb Z; Delaissé JM
    J Cell Biol; 2000 Nov; 151(4):879-89. PubMed ID: 11076971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host matrix metalloproteinase-9 contributes to tumor vascularization without affecting tumor growth in a model of prostate cancer bone metastasis.
    Nabha SM; Bonfil RD; Yamamoto HA; Belizi A; Wiesner C; Dong Z; Cher ML
    Clin Exp Metastasis; 2006; 23(7-8):335-44. PubMed ID: 17136575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.